February 28, 2014 / 2:55 PM / 4 years ago

BRIEF-GSK files with FDA for Promacta sNDA

Feb 28 (Reuters) - GlaxoSmithKline Plc : * Press release: GSK announces submission to U.S. regulatory authorities for

Promacta (eltrombopag) for severe aplastic anaemia * Announced today the submission of a supplemental new drug application (snda)

to the U.S. food and drug administration (fda) for Promacta * Application based on results from phase II nih study of eltrombopag in 43

heavily pre-treated saa patients *

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below